SSRP1 and central nervous system cancer: To further elucidate the involvement of SSRP1 in the advancement of GBM cells, various techniques, such as CCK-8 and EdU assays, as well as FACS analysis, have been employed.36 The results have revealed that silencing SSRP1 through siRNA leads to a significant reduction in the survival and replication capabilities of glioma cells.